Drug combination found to keep chronic lymphocytic leukemia in young patients in remission for several years
by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainYoung patients with chronic lymphocytic leukemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefi
Updated on: February 20,2024
Drug combination found to keep chronic lymphocytic leukemia in young patients in remission for several years
by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainYoung patients with chronic lymphocytic leukemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefi
Updated on:February 20,2024
